Skip to main content

Advertisement

Table 4 Summary of initial survey respondents affiliated trial subject areas

From: Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership – the PRioRiTy (Prioritising Recruitment in Randomised Trials) study

Trial subject area Number Percentage
Oncology/haematology – cancer 142 20
Neurology – neurodegenerative diseases, vascular Diseases 93 13
Cardiovascular diseases 44 6
Mental health 42 6
Metabolism – diabetes mellitus 38 5
Orthopaedics/musculoskeletal 34 5
Reproductive Health 34 5
Gastroenterology – hepatology, nephrology 29 4
Paediatrics/neonates 22 3
Respiratory 20 3
Inflammatory conditions (e.g. osteoarthritis, rheumatoid arthritis, fibromyalgia) 15 2
Surgery 15 2
Ophthalmology 14 2
Vaccines – preventive vaccines 13 2
Dementia/ageing 12 2
Infectious diseases 9 1
Dermatology 7 1
Palliative care 4 1
Involved in multiple trials 38 5
Other 79 11
Totala 704 100%
  1. aData were missing or response was “Do not know” in 86 respondents